Dexcom (DXCM)

R&D Expense Growth

5.30%

Quarterly · Period ending:

DXCM logo

DXCM R&D Expense Growth

Latest reported5.30%
DXCM Quarterly R&D Growth (QoQ) (0.00% → 5.30%)
High-resolution chart · PNG

DXCM r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Dexcom R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
5.2994%
-1.9568%
-5.9048%
6.2753%
2.0661%
4.086%
3.0281%
-0.4412%
-3.8869%
3.9677%
3.5769%
10.1425%
0.2521%
2.3216%
5.4397%
-9.3673%
-10.4489%
-42.634%
83.9286%
-0.2324%
18.0073%
-8.2215%
35.9179%
9.7622%
9.3023%
-7.2335%
18.1409%
-3.3333%
16.9492%
-78.5688%
449.501%
6.1441%
5.3571%
-8.0082%
12.4711%
-4.415%
-5.8212%
10.0686%
-0.4556%
20.9366%
12.7329%
12.9825%
-56.0185%
165.5738%
23.2323%
-8.3333%
16.7568%
25%
2.069%
15.0794%
6.7797%
6.3063%
19.3548%
6.8352%
-17.7377%
0.8002%
8.0597%
5.2318%
12.1613%
17.3176%
11.9336%
-9.1857%
12.0273%
13.5668%
14.4756%
13.5906%
19.3364%
1.1867%
8.9562%
-30.6279%
-15.6331%
12.9456%
-0.9498%
10.1433%
19.7766%
-8.863%
-0.1735%
2.6747%
-15.1973%
-13.5647%
-2.4147%
-49.8068%
117.0512%
1.291%
-8.3966%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.